ClinConnect ClinConnect Logo
Search / Trial NCT06098703

CARD for Community Pharmacy Vaccinations

Launched by UNIVERSITY OF TORONTO · Oct 19, 2023

Trial Information

Current as of August 24, 2025

Not yet recruiting

Keywords

Vaccination Reaction Vaccination Experience

ClinConnect Summary

This clinical trial, called CARD for Community Pharmacy Vaccinations, is looking to improve how vaccinations are given in community pharmacies. The goal is to see how using a special program called CARD can help both people getting vaccinated and the pharmacy staff who assist them. Researchers want to understand the effects on vaccine clients—those receiving shots—and on the pharmacy team involved in the process.

To participate, individuals must be receiving a vaccine at a community pharmacy that is taking part in the study. This includes people of all ages and genders who can understand and read English. However, if someone cannot read or understand English, they won't be able to join. Participants can expect to be part of a system that aims to make vaccinations more comfortable and effective. It's important to know that this trial is not yet recruiting participants, so there's still time to learn more about it before it starts.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • vaccine clients being vaccinated in community pharmacies participating in the project
  • pharmacy staff in community pharmacies participating in the project
  • Exclusion Criteria:
  • unable to understand and read English

About University Of Toronto

The University of Toronto, a prestigious research institution, serves as a leading sponsor of clinical trials dedicated to advancing medical knowledge and improving patient care. With a commitment to innovation and excellence, the university fosters a collaborative environment that brings together multidisciplinary teams of experts in medicine, pharmacology, and public health. Through rigorous research methodologies and ethical standards, the University of Toronto aims to explore new therapies, assess treatment efficacy, and address critical health challenges, ultimately contributing to the global body of scientific knowledge and enhancing healthcare outcomes.

Locations

Toronto, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Anna Taddio, PhD

Principal Investigator

University of Toronto

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported